Monterey Bio Acquisition Corp (MTRY) Key Ratios

Stock Card

$11.14

$0.00 (0.00%)

As on 29-Nov-2023 09:30EDT

Market cap

$48 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

P/B Ratio

2.5

Div. Yield

0 %

Key Ratios and Highlights

Growth Score (%)	Quarterly		Annual (TTM)
Particulars	QoQ	YoY	1-Year	3-Years	5-Years
Revenue	--	--	--	--	--
EBIT	-187.49	-6.64	-8.55	--	--
Net Profit	50.67	19.79	-324.20	--	--
EPS	50.67	19.79	-6.12	--	--
Book Value	--	--	-83.14	--	--

Key Ratios (%)	Average		Annual (TTM)
Particulars	3-Years	5-Years	TTM	Dec-22	Dec-21
EBIT-Margin	--	--	--	--	--
Net Margin	--	--	-134.63	-144.58	962.56
Return on equity	--	--	-6.06	-1.86	-0.99
Return on Capital	--	--	--	-1.86	-0.99
Return on Assets	--	--	-1.66	-1.84	-0.99
Debt to Equity (x)	--	--	0.00	--	--

Profitability

View Detailed Peer Comparison

ROCE

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Monterey Bio Acquisition Corp (MTRY)	--	-1.86	-0.99	--	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

ROE

-6.06

Lower than Peers by 30.11

Profit after tax / Average Net worth * 100

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Monterey Bio Acquisition Corp (MTRY)	-6.06	-1.86	-0.99	--	--
Peer Median	24.06	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

ROA

-1.66

Higher than Peers by 0.91

Profit after tax / Average Total assets * 100

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Monterey Bio Acquisition Corp (MTRY)	-1.66	-1.84	-0.99	--	--
Peer Median	-2.58	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Net Margin

-134.63

Net profit / Total Income (Net sales plus other income) * 100

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Monterey Bio Acquisition Corp (MTRY)	-134.63	-144.58	962.56	--	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

EBIT Growth

-8.55

Lower than Peers by 66.33

Year on year growth in operating profit (EBIT)

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Monterey Bio Acquisition Corp (MTRY)	-8.55	-289.95	-21,686.75	--	--
Peer Median	57.78	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Net Profit Growth

-324.20

Lower than Peers by 295.52

Year on year growth in profit after tax

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Monterey Bio Acquisition Corp (MTRY)	-324.20	-119.31	--	--	--
Peer Median	-28.68	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

EPS Growth

-6.12

Lower than Peers by 10.82

Year on year growth in earnings per share

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Monterey Bio Acquisition Corp (MTRY)	-6.12	-1.19	--	--	--
Peer Median	4.70	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Book Value Growth

-83.32

Lower than Peers by 69.21

Year on year growth in book value per share

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Monterey Bio Acquisition Corp (MTRY)	-83.32	--	--	--	--
Peer Median	-14.11	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

Total debt / Net worth

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Monterey Bio Acquisition Corp (MTRY)	--	--	--	--	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Short term debt to equity ratio

0.10

(Short term borrowings / Net worth)

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Monterey Bio Acquisition Corp (MTRY)	0.10	--	--	--	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Current Ratio

0.18

Higher than Peers by 0.04

Current Assets / Current Liabilities and Provisions

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Monterey Bio Acquisition Corp (MTRY)	0.18	0.23	3.25	25.00	--
Peer Median	0.15	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Quick Ratio

0.18

Higher than Peers by 0.05

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Monterey Bio Acquisition Corp (MTRY)	0.18	--	--	--	--
Peer Median	0.13	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Interest Coverage

-0.03

Lower than Peers by 1.69

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Monterey Bio Acquisition Corp (MTRY)	-0.03	-2.31	-4.25	--	--
Peer Median	1.66	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Asset Turnover

Sales / Average Total Assets

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Monterey Bio Acquisition Corp (MTRY)	--	--	--	--	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Payable days

Average Creditors / Cost of goods sold * 365

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Monterey Bio Acquisition Corp (MTRY)	--	146.16	--	--	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

Current share price divided by earning per share in the last twelve months

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Monterey Bio Acquisition Corp (MTRY)	--	-24.73	-50.87	--	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Price / Book Value

2.49

Lower than Peers by 0.91

Current share price divided by book value per share in the latest financial year

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Monterey Bio Acquisition Corp (MTRY)	2.49	1.60	0.25	--	--
Peer Median	3.39	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Dividend Yield

Dividend per share in the past twelve months divided by current share price

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Monterey Bio Acquisition Corp (MTRY)	--	--	--	--	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

EV/EBITDA

-24.45

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Monterey Bio Acquisition Corp (MTRY)	-24.45	--	-63.11	--	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Market Cap

Higher than Peers by 39

Current Share price multiplied by latest total number of shares outstanding

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Monterey Bio Acquisition Corp (MTRY)	48	--	--	--	--
Peer Median	9	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly